Strategic Investment ProSomnus recently secured a $38 million strategic investment from Catalio Capital Management to scale Smart Sleep Medicine, signaling strong growth momentum and potential for expanded distribution and partner programs that sales teams can leverage to identify co-selling and integration opportunities.

Remote Monitoring Tie‑ins Recent collaboration with MonitAir to integrate ProSomnus RPMO device data into MonitAir’s remote monitoring platform creates a measurable channel for selling bundled solutions to clinics seeking end‑to‑end OSA management and telehealth capabilities.

Growth & Recognition Consistent growth indicators include Inc. 5000 recognition and top manufacturing placement in the Bay Area, signaling credibility and ongoing demand which can be used to approach multi‑site health systems, clinics, and payers with scalable rollouts.

Insurance Coverage Advantage FDA‑cleared, patented intraoral devices already covered by commercial plans, Medicare, TRICARE and many government programs covering hundreds of millions of lives, highlighting a ready path for payer conversations and adoption across varied patient segments.

Expansion Readiness With a mid‑size team and a revenue range of 25–50 million, plus recent EVO Guided launch, there is a clear appetite for channel partners, distributors, and OEM collaborations to extend market reach and accelerate deployments in new markets.